Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brent Goslin

Surgery Columbus, OH Medical Doctor

NPI 1073741195 CMS profile 276176

3545 Olentangy River Rd Ste 525, Columbus, OH 43214

Open in the dashboard

General payments

$4,999

223 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brent Goslin of Columbus, OH is reported in the CMS Open Payments database as having received $4,999 across 223 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 68th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $827 30
2024 General $646 25
2023 General $761 29
2022 General $712 32
2021 General $676 36
2020 General $559 29
2019 General $818 42

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brent Goslin
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Brent Goslin were reported at $827. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Brent Goslin Surgery median Middle half National median
2019 $818 $253 $82–$1,521 $163
2020 $559 $131 $40–$706 $114
2021 $676 $168 $50–$904 $132
2022 $712 $224 $76–$1,218 $149
2023 $761 $253 $82–$1,255 $160
2024 $646 $279 $90–$1,381 $164
2025 $827 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Davol Inc. $543 14 payments
  2. Takeda Pharmaceuticals U.S.A., Inc. $514 20 payments
  3. Ethicon US, LLC $461 25 payments
  4. CSL Behring $445 22 payments
  5. Smith+Nephew, Inc. $345 18 payments
  6. Medtronic, Inc. $222 6 payments
  7. Acumed LLC $166 3 payments
  8. Merck Sharp & Dohme Corporation $130 9 payments
  9. DePuy Synthes Sales Inc. $125 4 payments
  10. CONMED Corporation $122 5 payments
  11. Other $1,925 97 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,945 219 payments
  2. Education $45 3 payments
  3. Consulting Fee $8 1 payment
Products named General payments · program years 2019–2025
  1. GATTEX $553 23 payments
  2. Kcentra $445 22 payments
  3. Snowden-Pencer $259 4 payments
  4. RibLoc $166 3 payments
  5. COLLAGENASE SANTYL $149 6 payments
  6. Phasix Mesh $149 5 payments
  7. LINX Reflux Management System $136 3 payments
  8. MATRIXRIB $125 4 payments
  9. PHASIX $121 3 payments
  10. DIFICID $112 8 payments
  11. Other $3,608 175 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

73

Median for General Surgery: 59

Drug cost

$533

Median for General Surgery: $393

Branded share of claims

24.7%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Omeprazole Generic 14 $259
Pantoprazole Sodium Generic 15 $84
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 18 $79
Oxycodone Hcl Generic 12 $60
Amitriptyline Hcl Generic 14 $51

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 71 billing codes

Paid by Medicare

$114,412

Medicare's payments for the services billed

Medicare patients

289

Average age 74

Services billed

724

168 women, 121 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 57%
Ischemic heart disease 45%
Depression 39%
Atrial fibrillation 38%
Chronic kidney disease 36%
Diabetes 34%
Heart failure 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Kcentra
  • CSL Behring $98
$98 — —
GATTEX
  • Takeda Pharmaceuticals U.S.A., Inc. $70
$70 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

223 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record